Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

3.830 -0.070 (-1.79%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	108,364
Open	3.880
Bid (Size)	3.720 (1,000)
Ask (Size)	4.150 (300)
Prev. Close	3.900
Today's Range	3.830 - 4.020
52wk Range	2.625 - 6.608
Shares Outstanding	46,322,655
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

Today 16:05 EDT

From KORU Medical Systems, Inc.

Via Business Wire

Koru Medical (KRMD) Q1 2026 Earnings Transcript ↗

May 07, 2026

Koru Medical (KRMD) Q1 2026 Earnings Transcript

Via The Motley Fool

Performance

YTD	-31.7%	-31.7%
1 Month	-11.5%	-11.5%
3 Month	-18.0%	-18.0%
6 Month	-14.7%	-14.7%
1 Year	+29.0%	+29.0%

More News

KORU Medical Systems (NASDAQ:KRMD) Soars 16% After Q1 Earnings Beat ↗

May 06, 2026

Via Chartmill

KORU Medical Systems Announces First Quarter 2026 Results

May 06, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Inc (NASDAQ:KRMD) Shows Minervini Trend Template and Growth Momentum Alignment ↗

January 28, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026

April 16, 2026

From KORU Medical Systems Inc.

Via Business Wire

KORU Medical (KRMD) Q4 2025 Earnings Transcript ↗

March 17, 2026

Via The Motley Fool

KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility

March 13, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Announces CEO Transition

March 12, 2026

From KORU Medical Systems

Via Business Wire

KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

March 12, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

February 26, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

January 29, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow

January 12, 2026

From KORU Medical Systems

Via Business Wire

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 05, 2026

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

December 30, 2025

From KORU Medical Systems

Via Business Wire

KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer

December 16, 2025

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

November 17, 2025

From KORU Medical Systems

Via Business Wire

KORU Medical Systems to Participate in Upcoming Investor Conferences

November 13, 2025

From KORU Medical Systems

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

November 12, 2025

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

November 04, 2025

From KORU Medical Systems, Inc.

Via Business Wire

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

October 22, 2025

From KORU Medical Systems, Inc.

Via Business Wire

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

September 18, 2025

Via ACCESS Newswire

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

September 18, 2025

From ForCast Orthopedics, Inc.

Via Business Wire

Frequently Asked Questions

Is KORU Medical Systems, Inc. - Common Stock publicly traded?

Yes, KORU Medical Systems, Inc. - Common Stock is publicly traded.

What exchange does KORU Medical Systems, Inc. - Common Stock trade on?

KORU Medical Systems, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for KORU Medical Systems, Inc. - Common Stock?

The ticker symbol for KORU Medical Systems, Inc. - Common Stock is KRMD on the Nasdaq Stock Market

What is the current price of KORU Medical Systems, Inc. - Common Stock?

The current price of KORU Medical Systems, Inc. - Common Stock is 3.830

When was KORU Medical Systems, Inc. - Common Stock last traded?

The last trade of KORU Medical Systems, Inc. - Common Stock was at 05/18/26 04:00 PM ET

What is the market capitalization of KORU Medical Systems, Inc. - Common Stock?

The market capitalization of KORU Medical Systems, Inc. - Common Stock is 177.42M

How many shares of KORU Medical Systems, Inc. - Common Stock are outstanding?

KORU Medical Systems, Inc. - Common Stock has 177M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.